Oncopeptides AB (ONPPF)
0.265
0.00 (0.00%)
USD |
OTCM |
Sep 19, 16:00
Oncopeptides EPS Diluted (TTM): -0.2711 for Sept. 30, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.2711 |
| June 30, 2023 | -0.3247 |
| March 31, 2023 | -0.3465 |
| December 31, 2022 | -0.4113 |
| September 30, 2022 | -0.8523 |
| June 30, 2022 | -1.953 |
| March 31, 2022 | -1.910 |
| December 31, 2021 | -2.182 |
| September 30, 2021 | -2.542 |
| June 30, 2021 | -1.991 |
| March 31, 2021 | -2.655 |
| December 31, 2020 | -2.801 |
| September 30, 2020 | -2.367 |
| June 30, 2020 | -2.090 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.761 |
| December 31, 2019 | -1.206 |
| September 30, 2019 | -1.026 |
| June 30, 2019 | -0.8969 |
| March 31, 2019 | -0.9054 |
| December 31, 2018 | -1.095 |
| September 30, 2018 | -1.012 |
| June 30, 2018 | -0.9332 |
| March 31, 2018 | -0.7439 |
| December 31, 2017 | -0.7632 |
| September 30, 2017 | -0.7404 |
| June 30, 2017 | -0.655 |
| March 31, 2017 | -0.5367 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-2.801
Minimum
Dec 2020
-0.2711
Maximum
Sep 2023
-1.57
Average
-1.910
Median
Mar 2022
EPS Diluted (TTM) Benchmarks
| Abliva AB | -0.0085 |
| Karolinska Development AB | -0.0028 |
| Calliditas Therapeutics AB | -1.696 |
| BioInvent International AB | -0.5489 |
| Hansa Biopharma AB | -1.373 |